Carcinoma ex-pleomorphic adenoma derived from recurrent pleomorphic adenoma shows important difference by array CGH compared to recurrent pleomorphic adenoma without malignant transformation

被引:7
作者
Mariano, Fernanda Viviane [1 ]
Giovanetti, Karina [1 ]
Vidal Saccomani, Luis Fernando [1 ]
Del Negro, Andre [2 ]
Kowalski, Luiz Paulo [3 ]
Victorino Krepischi, Ana Cristina [4 ]
Altemani, Albina [1 ]
机构
[1] Univ Estadual Campinas UNICAMP, Fac Ciencias Med, Dept Patol, Campinas, SP, Brazil
[2] Univ Estadual Campinas UNICAMP, Fac Ciencias Med, Dept Cirurgia Cabeca & Pescoco, Campinas, SP, Brazil
[3] AC Camargo Canc Ctr, Dept Cirurgia Cabeca & Pescoco, Sao Paulo, SP, Brazil
[4] Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Sao Paulo, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
Carcinoma ex-pleomorphic adenoma; Recurrent pleomorphic adenoma; Somatic copy number alterations; aCGH; PAROTID-GLAND; CELL CARCINOMAS; LUNG-CANCER; HMGA2; REARRANGEMENT; AMPLIFICATION; EXPRESSION; PROTEINS; CYCLE;
D O I
10.1016/j.bjorl.2015.12.004
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Introduction: A key step of cancer development is the progressive accumulation of genomic changes resulting in disruption of several biological mechanisms. Carcinoma ex-pleomorphic adenoma (CXPA) is an aggressive neoplasm that arises from a pleomorphic adenoma. CXPA derived from a recurrent PA (RPA) has been rarely reported, and the genomic changes associated with these tumors have not yet been studied. Objective: We analyzed CXPA from RPAs and RPAs without malignant transformation using array comparative genomic hybridization (array-CGH) to identify somatic copy number alterations and affected genes. Methods: DNA samples extracted from FFPE tumors were submitted to array-CGH investigation, and data was analyzed by Nexus Copy Number Discovery Edition v.7. Results: No somatic copy number alterations were found in RPAs without malignant transformation. As for CXPA from RPA, although genomic profiles were unique for each case, we detected some chromosomal regions that appear to be preferentially affected by copy number alterations. The first case of CXPA-RPA (frankly invasive myoepithelial carcinoma) showed copy number alterations affecting 1p36.33p13, 5p and chromosomes 3 and 8. The second case of CXPA-RPA (frankly invasive epithelial-myoepithelial carcinoma) showed several alterations at chromosomes 3, 8, and 16, with two amplifications at 8p12p11.21 and 12q14.3q21.2. The third case of CXPA-RPA (minimally invasive epithelial-myoepithelial carcinoma) exhibited amplifications at 12q13.3q14.1, 12q14.3, and 12q15. Conclusion: The occurrence of gains at chromosomes 3 and 8 and genomic amplifications at 8p and 12q, mainly those encompassing the HMGA2, MDM2, WIF1, WHSC1L1, LIRG3, CDK4 in CXAP from RPA can be a significant promotional factor in malignant transformation. (C) 2016 Associacao Brasileira de Otorrinolaringologia e Cirurgia Cervico-Facial. Published by Elsevier Editora Ltda.
引用
收藏
页码:687 / 694
页数:8
相关论文
共 28 条
[1]  
Abe N, 2000, CANCER RES, V60, P3117
[2]   PLAG1 Alteration in Carcinoma Ex Pleomorphic Adenoma: Immunohistochemical and Fluorescence In Situ Hybridization Studies of 22 Cases [J].
Bahrami A. ;
Dalton J.D. ;
Shivakumar B. ;
Krane J.F. .
Head and Neck Pathology, 2012, 6 (3) :328-335
[3]  
Bradley P, 2001, CURR OPIN OTOLARYNGO, V9, P100
[4]   MALIGNANCY IN PLEOMORPHIC ADENOMA - CLINICAL AND MICROSPECTROPHOTOMETRIC STUDY [J].
ENEROTH, CM ;
ZETTERBERG, A .
ACTA OTO-LARYNGOLOGICA, 1974, 77 (06) :426-432
[5]  
Eveson JW, 2005, WHO CLASSIFICATION T, P254
[6]   Chromothripsis and cancer: causes and consequences of chromosome shattering [J].
Forment, Josep V. ;
Kaidi, Abderrahmane ;
Jackson, Stephen P. .
NATURE REVIEWS CANCER, 2012, 12 (10) :663-670
[7]   Roles of HMGA proteins in cancer [J].
Fusco, Alfredo ;
Fedele, Monica .
NATURE REVIEWS CANCER, 2007, 7 (12) :899-910
[8]  
Gupta Ashumi, 2013, J Oral Maxillofac Pathol, V17, P427, DOI 10.4103/0973-029X.125213
[9]   The hallmarks of cancer [J].
Hanahan, D ;
Weinberg, RA .
CELL, 2000, 100 (01) :57-70
[10]  
LACCOURREYE H, 1994, LARYNGOSCOPE, V104, P1487